🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypothesis of this Phase 2, 12-week study, is that DS-8500a will improv...
Status
Completed
Location
Multiple Locations
Start Date
2016-01
Trial ID
NCT02647320
Treatments Being Tested
This study will evaluate the efficacy and safety of 100 mg DRBP108 tablets ...
Status
Completed
Location
Peking University First Hospital
Start Date
2020-01-02
Trial ID
NCT04161430
The purpose of the study is to assess the effect of the addition of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02532855
A clinical study determines the safety and efficacy of sitagliptin (MK0431)...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-03
Trial ID
NCT00758069
Treatments Being Tested
To define the relative efficacy, safety and tolerability profiles of oral d...
Status
Completed
Location
Impact Clinical Trials
Start Date
2009-12
Trial ID
NCT01035879
Treatments Being Tested
This trial is conducted in Europe and North America. The aim of this trial ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2008-06
Trial ID
NCT00700817
Treatments Being Tested
To evaluate the effect of treatment with sitagliptin compared to placebo in...
Status
Completed
Location
Multiple Locations
Start Date
2006-03-08
Trial ID
NCT00305604
Treatments Being Tested
The purpose of this study is to examine the insulin-sparing effect of sitag...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-13
Trial ID
NCT01462266
Treatments Being Tested
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455909
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-15
Trial ID
NCT00541450